Botanical Source

(-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1,2)-β-D-glucopyranoside is a lignan glycoside, which is a type of secondary metabolite. This compound is primarily derived from plant sources, often isolated from the heartwood of various trees or other lignan-rich plant materials. The extraction typically involves advanced chromatographic techniques that separate and purify it from complex plant matrices.

Pelargonidin-3-O-sophoroside is a specialized flavonoid glycoside, which is derived from certain plant sources. It is primarily isolated from various fruits and flowers where it contributes to pigmentation, specifically imparting hues such as red and pink. The compound functions through its role as a pigment by absorbing specific wavelengths of light, which can protect the plant tissues from excess UV radiation and attract pollinators.

a-Glucosylrutin is a flavonoid glycoside derivative, which is synthesized from rutin, a natural flavonoid extracted from plants such as buckwheat and citrus fruits, using an enzymatic glucosylation process. The incorporation of glucose enhances its stability and solubility compared to its parent compound, rutin.

Notoginsenoside R1 is a saponin compound, which is a key bioactive ingredient derived from the roots of Panax notoginseng, a well-known traditional medicinal plant. This product is renowned for its diverse pharmacological activities, particularly its anti-inflammatory and antioxidant effects. The mode of action of Notoginsenoside R1 involves modulating various signaling pathways, including the NF-κB and MAPK pathways, which are pivotal in regulating the body's inflammatory response. Additionally, it exhibits the ability to scavenge free radicals, contributing to its antioxidative properties.

Empagliflozin 6-O-β-D-glucuronide is a metabolite of the drug empagliflozin, which is a type of product known as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. This compound is derived from the in vivo metabolism of empagliflozin, originally sourced from synthetic pathways designed to enhance the management of type 2 diabetes mellitus. Its mode of action involves the facilitation of glucose excretion through the kidneys by inhibiting renal reabsorption of glucose, thus lowering blood glucose levels.

Scandoside methyl ester is a naturally occurring iridoid glycoside derivative, which is typically isolated from certain plant species, particularly those in the genus Scrophularia. This compound is part of a class of secondary metabolites known for their diverse biological activities. Its mechanism of action is often linked to its ability to interact with various biological pathways, including those involved in anti-inflammatory and antioxidant responses. Researchers have explored its potential to inhibit specific enzymes and modulate signaling pathways.

Phloretin 2'-O-xylosyl-glucoside is a natural glycoside compound, which is derived from the xylosylation and glucosylation of phloretin, commonly found in certain fruits like apples. It is a biochemical derivative formed through enzymatic reactions involving specific glycosyltransferases in plant tissues. The mode of action of this compound primarily involves its antioxidant properties, where it serves to neutralize free radicals and reduce oxidative stress within biological systems.

Momordin 2e is a cucurbitane triterpenoid compound, which is derived from natural plant sources, particularly within the gourd family, Cucurbitaceae. This product has garnered attention due to its bioactive properties, primarily identified in plants such as bitter melon (Momordica charantia).

Rebaudioside I is a steviol glycoside, which is a high-intensity sweetener derived from the leaves of the Stevia rebaudiana plant. As a natural compound, it is extracted and purified through a water or alcohol-based process from the plant’s leaves, which have been traditionally used for their sweetening properties.